Study: Aspirin anti-cancer
A study conducted by the US National Institutes of Health showed that small doses of aspirin may increase the chances of overcoming cancer. The scientific work has been published on the JAMA Network website.
The researchers examined more than 140,000 US citizens, collected on average over more than 12.5 years, and found that those who drank aspirin one to three times a week had a lower mortality rate after developing prostate, colon, lung and ovarian cancer.
However, the researchers confirm, this happened only in people with normal weight – in people who are under or overweight, such an effect of aspirin is not found.
Authors of scientific work also recognized that further studies are needed to determine the relationship between BMI and the effectiveness of aspirin as a potential cancer prevention tool.
In recent years, scientists have been interested in aspirin and other drugs containing salicylic acid, which, as experiments have shown, have strong anti-cancer properties. According to medical experimenters, aspirin is able to increase the effectiveness of immunotherapy several times, as well as fight leukemia, colorectal cancer and a number of other tumors independently and increase the chances of survival after chemotherapy by 15-20 percent.
On the other hand, many regulatory bodies, including the FDA, do not recommend or even prohibit taking aspirin because it can cause bleeding, strokes and ulcers, because it has the property of dissolving blood clots in the blood vessels of the brain and intestines.
December 6, 2019